<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/272078-method-of-synthesis-of-stable-forms-of-loperamide-n-oxide-4-4-4-chlorophenyl-4-hydroxypiperidin-1-yl-n-n-dimethyl-2-2-di-phenyl-butanamide-n-oxide-and-stable-loperamide-n-oxide-made-thereby by HTTrack Website Copier/3.x [XR&CO'2014], Thu, 04 Apr 2024 23:34:10 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 272078:METHOD OF SYNTHESIS OF STABLE FORMS OF LOPERAMIDE N-OXIDE: (4-[4-(4-CHLOROPHENYL)-4- HYDROXYPIPERIDIN-1-YL]-N,N-DIMETHYL-2,2-DI(PHENYL)BUTANAMIDE) N-OXIDE AND STABLE LOPERAMIDE N-OXIDE MADE THEREBY</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">METHOD OF SYNTHESIS OF STABLE FORMS OF LOPERAMIDE N-OXIDE: (4-[4-(4-CHLOROPHENYL)-4- HYDROXYPIPERIDIN-1-YL]-N,N-DIMETHYL-2,2-DI(PHENYL)BUTANAMIDE) N-OXIDE AND STABLE LOPERAMIDE N-OXIDE MADE THEREBY</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>A novel aqueous based method of synthesis A novel method of synthesis of (4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-di(phenyl)butanamide) N-oxide (Loperamide N-Oxide is disclosed . The invention also provides the product by the method disclosed. The method to produce the compound is capable of being carried out at low temperatures not exceeding about 50°C.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>The present invention provides novel method of synthesis of Stable forms of Loperamide N-Oxide: (4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-di(phenyl)butanamide) N -Oxide.<br>
Particularly the present invention provides the synthesis of 4-[4-(4-chlorophenyl)-<br>
4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-di(phenyl)butanamide)	N-oxide<br>
(Loperamide N-Oxide) comprising reacting 4-[4-(4-chlorophenyl)-4-<br>
hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-di(phenyl)butanamide	(Loperamide<br>
Base)  with an organic anhydride  in the presence of hydrogen peroxide.<br>
.Loperamide N-oxide (4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-di(phenyl)butanamide N-Oxide) dehydrate, is the metabolite of the original drug Loperamide. Loperamide N-oxide has lower toxicity and has faster action. Literature procedures are known for the synthesis of N-Oxides from the original drug, and these involve the use of hydrogen peroxide , with or with out catalysts like sodium tungstate/tungstic acid or sodium moiybdate in the presence of organic solvents like methanol.<br>
Patent US4898873 assigned to Wals et a! discloses the synthesis of alpha., .alpha.-DiaryM-aryl-4-hydroxyl-1-piperidinebutanamide.N-oxides (Loperamide N-Oxide) .The procedure disclosed in the patent is tedious and involves a method to remove the organic solvents and inorganic catalysts to the required levels. The procedure requires multiple purification steps to get pharmaceutically acceptable pure compounds.<br>
A convenient, high yielding method of preparing a form of stable Loperamide N-Oxide,(4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-di(phenyl)butanamide is thus desired.<br>
It is an object of the present invention to provide novel method of synthesis of Stable fonns of Loperamide N-Oxide: (4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-di(phenyl)butanamide) N -Oxide..<br><br>
Another object of the present invention is to provide synthesis of Stable fomris of<br>
Loperamide N-Oxide comprising reaction with an organic anhydride     in the<br>
presence of hydrogen peroxide.<br>
Still another object of the present invention is to provide a high purity N -oxide of<br>
at least 99.5%.<br>
In the   drawing accompanying this specification Fig 1; represents the   novel<br>
alpha,alpha-diaryl-4-aryl-4-hydroxy-l-piperldinebutanamide,N-oxldes<br>
(Loperamide N-Oxide. Fig 2 represents a general formula. Fig 3 represents the<br>
formula of the starting material which is used to do N oxidation<br>
Accordingly the present invention provides   novel method of synthesis of Stable<br>
forms of   Loperamide N-Oxide: (4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-<br>
N,N-dimethyl-2,2-di(phenyl)butanamide) N -Oxide comprising   reacting (4-[4-(4-<br>
chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-di(phenyl)butanamide)<br>
(Loperamide Base)   with an organic anhydride   in the presence of hydrogen<br>
peroxide, thereby giving stable 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-<br>
N,N-dimethyl-2,2-di(phenyl)butanamide)n-Oxide<br>
In an embodiment of the present invention , the anhydride  may be selected<br>
from pthalic, acetic, maleic and succinic anhydride.<br>
In another embodiment of the present invention hydrogen peroxide may be in a<br>
concentration range between about 1% and about 90%.<br>
In still another embodiment of the present invention the  reaction may be carried<br>
out for a time in a range between about 2 hours and 6 hours.<br>
In yet another embodiment of the present invention reaction may be conducted at<br>
temperatures in a range between about 40 °C and about 80 °C.<br>
In still another embodiment of the   present invention provided is a method of<br>
formation of N-Oxides by reacting hydrogen peroxide with pharmaceutically<br>
active tertiary amines and imines.<br>
In yet another embodiment of the present invention said tertiary amines   may<br>
contain a    residual solvent selected from    ethyl acetate, or any ester ,<br>
toluene/hydrocarbon or acetone or any ketone.<br><br>
In still another embodiment of the present invention the said solvent may be present in an amount in the range between about 250ppm and about SOOppm in the finished product.<br>
Accordingly the present invention provides stable fomris of Loperamide N-Oxide obtained by the method of the invention<br>
The invention further discloses methods for oxidizing tertiary amines and imines to corresponding n-Oxide, the method exhibiting exemplary yields of the n-oxide.<br>
The present invention is concerned with novel alpha,alpha-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide, N-oxides (Loperamide N-Oxide) which may structurally be represented by the formula as given in Fig 1 and represented by a general formula as given in Fig 2(a). The exact mass of alpha,aipha-diaryl-4-aryl-4-hydroxy-l-piperidinebutanamide, N-oxIdes (Loperamide N-OxIde) is 492.22 and molecular weight is 493.04. and having a general fonnula shown in Fig 2(a) The pharmaaceutically acceptable acid addition salts and stereochemically isomeric forms thereof of Fomriula 2 as shown in Fig 2 (a), compounds, wherein R is hydrogen or methyl; Ar.^ and Ar. ^ are, each independently, phenyl or halophenyl; Alk is -CH.2 ~CH. 2~ or -CH. 2-CH(CH. 3)-; R.^ and R^ are, each independently, hydrogen, C.i^ alkyl, phenylmethyl or 2-propenyl or R.^ and R.^combined with the nitrogen atom bearing said R.^and R.^ may form a pyrrolidinyl, piperidinyl, C. .1-6 alkylpiperidinyl, 4-morpholinyl or 2,6-di(C. .1.6 alkyl)-4-morpholinyl radical;:<br>
Ar.^ is phenyl being optionally substituted with up to 3 substituents selected from the group consisting of C. 1^ alkyl, C. 1^ alkyloxy, halo and trifiuoromethyl. As used in the foregoing definitions the tenn halo is generic to fluoro, chloro, bromo and iodo: "C. 1^ alkyl" is meant to include straight and branched saturated hydrocarbon radicals, having from 1 to 6 carbon atoms, such as, for example, methyl, ethyl, 1-methylethyl, 1.1-dimethylethyl, propyl, butyl, pentyl, hexyl and the like. Preferred compounds within the invention are those wherein R.^ and R. ^ are both methyl and Ar^. and Ar. ^ are both phenyl.<br><br>
Preferred compounds are those compounds wherein Ar\ Ar^ and Ar^ are phenyl<br>
where in Ar^ is optionally substituted with one or two substituents independently<br>
selected from halo and trifluoromethyl<br>
More particularly preferred compounds within the invention are selected from the<br>
group consisting of 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-.alpha.,.alpha.-<br>
diphenyl-1-piper   idinebutanamide    N-oxide   (Loperamide   N-Oxide)    ,   the<br>
pharmaceutically acceptable  acid  addition  salts and  stereoisomeric forms<br>
thereof.<br>
The most preferred compounds within the invention are selected from the group<br>
consisting   of   trans-4-(4-chlorophenyl)-4-hydroxy-N,N-dlmethyl-.alpha.,.alpha.-<br>
diphenyl-1   -piperidinebutanamide N-oxide (Loperamide  N-Oxide)     and the<br>
pharmaaceutically acceptable acid addition salts thereof.<br>
The compounds of formula 1    may generally be prepared by N-oxidating a<br>
starting material with the formula as shown in Fig2 (b)<br>
Where Ar\ Ar^, Ar^...and Alkyl and R= H as  depicted in Fig 2.(a)<br>
The above said N-oxidation reaction may generally be carried out by reacting<br>
the starting material of formula 3 with an appropriate organic or inorganic<br>
anhydride in hydrogen peroxide. Appropriate anhydrides include for example<br>
pthalic anhydride, acetic anhydride, succinic anhydride, maleic anhydride, pivalic<br>
anhydride having a general formula (RC0)20) where in R is alyl, aryl or cyclic<br>
anhydride.<br>
Appropriate inorganic peroxides comprise, for example, hydrogen peroxide, alkali<br>
metal or earth alkaline metal peroxides, e.g. sodium peroxide, potassium<br>
peroxide, barium peroxide and the like. Appropriate organic peroxides comprise<br>
alkylhydroperoxides, e.g. t.butyl hydroperoxide and the like. Suitable solvents<br>
are, for example, acetyl acetate.ethyl acetate,   methyl acetate, butyl acetate,<br>
amyl acetate and the like,    water, lower alkanols, e.g. methanol, ethanol,<br>
propanol, butanol and the like,   hydrocarbons, e.g. benzene, methylbenzene,<br>
dimethylbenzene and the like, ketones, e.g. 2-propanone, 2-butanone and the<br>
like, halogenated hydrocarbons, e.g. dichloromethane, trichloromethane and the<br>
like, and mixtures of such solvents. In order to enhance the reaction rate, it may<br><br>
be appropriate to heat the reaction mixture. The reaction may be conducted at temperatures in the range of 25°C to 75°C. In particular the reaction may be conducted in the range of 40°C to 50°C. The reaction may be earned out for at least a period of 5 to about 10 hours. The reactants may be stirred, cooled and separated from water.<br>
In all of the foregoing and in the following preparations, the reaction products may be isolated from the reaction mixture and, if necessary, further purified according to methodologies generally known in the art.<br>
The compounds of formula (I) have basic properties and, consequently, they may<br>
be converted to their therapeutically active non-toxic acid addition salt forms by<br>
treatment with appropriate acids, such as, for example, inorganic acids, such as<br>
hydrohalic acid, e.g. hydrochloric, hydrobromic and the like, and sulfuric acid,<br>
nitric acid, phosphoric acid and the like; or organic acids, such as, for example,<br>
acetic, propanoic, hydroxyacetic, 2-hydroxy-propanoic, 2-oxopropanoic,<br>
ethanedioic, propanedioic, butanedioic, (Z)-2-butenedioic, (E)-2-butenedioic, 2-<br>
hydroxybutanediolc,	2,3-dihydroxybutanedioic,	2-hydroxy-1,2,3-<br>
propanetricarboxylic, methanesulfonic, ethanesulfonic, benzenesulfonic, 4-methylbenzenesulfonic, cyclohexanesulfamic, benzoic, 2-hydroxybenzoic, 3-phenyl-2-propenoic, .alpha.-hydroxybenzeneacetic, 4-amino-2-hydroxybenzoic and the like acids. Conversely the salt form can be converted by treatment with alkali into the free base fonn.<br>
The n-Oxide of the invention shows exemplary purity and can high yields. The process of the invention can give great benefits as the number of reaction steps are lower compared to procedures disclosed earlier. The process will give extensive procedural and economic benefits to manufacturing entities as the technical complexities and costs are lower compared to earlier disclosed methods. The purity of the compounds of the disclosed method are significantly higher compared to earlier disclosed methods.<br>
Following examples are given by way of illustration only  and do not limit the scope of the invention<br><br>
Procedure for synthesis of compounds of the type Formula 1as given in Fig 1:<br>
Example-1<br>
30% Hydrogen peroxide (278 mL pre stabilized with phosphoric acid, 0.001 to 2 %)<br>
was added to a suspension of (4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-<br>
dimethyl-2,2-di(phenyl)butanamide) Base (Loperamide base, 400 g, prepared by<br>
bascifying	(4-[4-(4-chlorophenyl)-4-hydroxyptpericKn-1 -yf]-N,N-dimethyl-2,2-<br>
di(phenyl)butanamide) Hydrochloride with sodium carbonate in methanol), ethyl acetate (4000 mL) and pthalic anhydride (400 g ) at 45 to 50 °C over a period of 4 h keeping the temperature below 50°C. Stir the reaction mixture at the same temperature for 6 h. Cool and add to aqueous sodium carbonate solution (572 g in 4 Lt water). The solid thus separated was filtered and washed with water to get (4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-di(phenyl)butanamide) N-Oxide (Loperamide N-Oxide) 350 g . This can be crystalized with acetone: methanol (1:1) to get pure (4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dlmethyl-2,2-di(phenyl)butanamide ) N-Oxide which &gt;99.5% pure by HPLC as per BP2009 HPLC method (about 275 g).<br>
The main advantages of the present invention are:<br>
1.	The present	invention gives pure (4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1 -yl]-N,N-dimethyl-2,2-di(phenyl)butanamide ) N-Oxide with a purity of at least 99.5%<br>
2.	The method is a low temperature process to prepare the compound.<br><br><br><br>
We Claim:<br>
1.	A novel method	of synthesis of (4-[4-(4-chlorophenyl)-4-<br>
hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-di(phenyl)butanamicle) N-oxide<br>
(Loperamide N-Oxide) comprising reacting (4-[4-(4-chlorophenyl)-4-<br>
hydroxypiperidin-1-yl]-N,N-dlmethyl-2,2-dl(phenyl)butanamlde)	base<br>
(Loperamide base) with an organic anhydride In presence of hydrogen<br>
peroxide<br>
2.	The method of claim 1 wherein said anhydride is an anhydride of organic or inorganic acids having the general formula (RC0)2 O with R being an alkyl or aryl group.<br>
3.	The method of claim 1 wherein said hydrogen peroxide Is in a concentration range between about 1% and about 90%.<br>
4.	The method of claim 1 wherein said reaction is carried out for a time In a range between about 2 hours and 6 hours.<br>
5.	The method of claim 1 wherein said reaction is conducted at temperatures in a range between about 40 °C and about 80 °C.<br>
6.	A method of formation of N-Oxides of claim 1 by reacting hydrogen peroxide with compounds selected from pharmaaceutically active tertiary amines and imines.<br>
7.	The method of claim 6, where said tertiary amines contain a residual solvent selected from ethyl acetate, or any ester, toluene/hydrocarbon or acetone or any ketone wherein said solvent Is present In an amount In the range between about 250ppm and about 500ppm In the finished product.<br>
8.	Stable forms of Loperamide N-Oxide obtained by the method of the invention as claimed In claims 1 to 7<br><br>
9.      A   novel   method	of   synthesis   of       (4-[4-(4-chlorophenyl)-4-<br>
hyclroxypiperidin-1-yl]-N,N-dimethyl-2,2-cli(phenyl)butanamicle) N-oxide (Loperamide N-Oxide substantially herein as described and illustrated in the figures of accompanying drawings<br><br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/viewdoc.aspx?id=6XknEyhntWu+rvlFvc59KA==&amp;amp;loc=egcICQiyoj82NGgGrC5ChA==" target="_blank" style="word-wrap:break-word;">http://ipindiaonline.gov.in/patentsearch/GrantedSearch/viewdoc.aspx?id=6XknEyhntWu+rvlFvc59KA==&amp;amp;loc=egcICQiyoj82NGgGrC5ChA==</a></p>
		<br>
		<div class="pull-left">
			<a href="272077-biodiesel-synthesis.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="272079-coated-pipes-having-improved-mechnical-properties-and-a-method-of-production-thereof.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>272078</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>3010/CHE/2009</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>12/2016</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>18-Mar-2016</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>16-Mar-2016</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>07-Dec-2009</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>R L FINE CHEM</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>HIG 2000, RAY HOUSE, YELAHANKA NEW TOWN, BANGALORE - 560 106.</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>ANDAGAR RAMAKRISHNA RAMESHA</td>
											<td>NO 15, R L FINE CHEM, KHB INDUSTRIAL AREA, YELAHANKA NEW TOWN, BANGALORE-560 106.</td>
										</tr>
										<tr>
											<td>2</td>
											<td>ROY. ANJAN KUMAR</td>
											<td>NO 15, R L FINE CHEM, KHB INDUSTRIAL AREA, YELAHANKA NEW TOWN, BANGALORE-560 106.</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C07D 211/52 ; A61K 31/445</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>N/A</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td></td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td></td>
									<td></td>
								    <td>NA</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/272078-method-of-synthesis-of-stable-forms-of-loperamide-n-oxide-4-4-4-chlorophenyl-4-hydroxypiperidin-1-yl-n-n-dimethyl-2-2-di-phenyl-butanamide-n-oxide-and-stable-loperamide-n-oxide-made-thereby by HTTrack Website Copier/3.x [XR&CO'2014], Thu, 04 Apr 2024 23:34:11 GMT -->
</html>
